Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

XERO LIMITED Share Issue/Capital Change 2016

Mar 31, 2016

66106_rns_2016-03-31_0bb6491a-955c-46e7-9b43-7b58039f358d.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Xero Limited

ABN

160 661 183 (ARBN)

We (the entity) give ASX the following information.

Part 1 -­ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or
to be issued



2
Number of+securities issued or
to be issued (if known) or
maximum number which may
be issued
Ordinary Shares
60,716 Ordinary Shares

3 Principal terms of the 34,944 Ordinary Shares were issued upon +securities (e.g. if options, vesting of 34,944 Restricted Stock Units exercise price and expiry date;; ( Restricted Stock Units or RSUs ) granted if partly paid[+] securities, the under the Xero Limited Restricted Stock Unit amount outstanding and due Plan (AU) ( AU Plan ) as part of the dates for payment;; if remuneration package of two key employees +convertible securities, the based in Australia. The RSUs vested subject to conversion price and dates for the terms of the AU Plan, including continued conversion) employment of the relevant employee with the Xero Limited Group on the relevant vesting date. 25,772 Ordinary Shares were issued upon vesting of 25,772 RSUs granted under the Xero Limited Restricted Stock Unit Plan (NZ) ( NZ Plan ) as part of the remuneration package of a key employee based in New Zealand. The RSUs vested subject to the terms of the NZ Plan, including continued employment of the relevant employee with the Xero Limited Group on the relevant vesting date

  • 4 Do the[+] securities rank equally Yes in all respects from the[+] issue date with an existing[+] class of quoted[+] securities? If the additional[+] securities do not rank equally, please state: • the date from which they do

  • • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

  • 5 Issue price or consideration 34,944 Ordinary Shares were issued upon vesting of 34,944 RSUs granted under the AU Plan as part of the remuneration package of two key employees based in Australia. 25,772 Ordinary Shares were issued upon vesting of 25,772 RSUs granted under the NZ Plan as part of the remuneration package of a key employee based in New Zealand. No cash consideration was required to be paid for the RSUs to vest

  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

6
Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)








6a
Is the entity an+eligible entity
that
has
obtained
security
holder
approval
under
rule
7.1A?

If Yes, complete sections 6b –
6h_in relation to the+securities_
the subject of this Appendix 3B,
and comply with section 6i


6b
The date the security holder
resolution under rule 7.1A was
passed


6c
Number of+securities issued
without security holder approval
under rule 7.1


6d
Number of+securities issued
with security holder approval
under rule 7.1A


6e
Number of+securities issued
with security holder approval
under rule 7.3, or another
specific
security
holder
approval
(specify
date
of
meeting)



6f
Number of+securities issued
under an exception in rule 7.2


6g
If+securities issued under rule
7.1A, was issue price at least
75% of 15 day VWAP as
calculated under rule 7.1A.3?
Include the+issue date and
both values. Include the source
of the VWAP calculation.


6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration, state date on
which valuation of consideration
was released to ASX Market
Announcements
34,944 Ordinary Shares were issued upon
vesting of 34,944 RSUs granted under the AU
Plan as part of the remuneration package of two
key employees based in Australia. 25,772
Ordinary Shares were issued upon vesting of
25,772 RSUs granted under the NZ Plan as part
of the remuneration package of a key employee
based in New Zealand
N/A

N/A

N/A

N/A

N/A

N/A
N/A

N/A

6i Calculate the entity’s remaining N/A issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements 7 +Issue dates 31 March 2016 Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. Number +Class 8 Number and +class of all 136,814,293 Ordinary +securities quoted on ASX ( including the +securities in section 2 if applicable) Number +Class 9 Number and +class of all 705,405 RSUs RSUs (a conditional +securities not quoted on ASX contractual right to be ( including the +securities in issued up to 705,405 section 2 if applicable) Ordinary Shares) – taking into account forfeited RSUs to date, and the RSUs that have vested as set out in this Appendix 3B 820,546 Options Unlisted options (convertible into Ordinary Shares on a 1:1 basis)

10 Dividend policy (in the case of a As for all Ordinary Shares trust, distribution policy) on the increased capital (interests)

Part 2 -­ Pro rata issue

11 Is security holder approval N/A required? 12 Is the issue renounceable or N/A non-­renounceable? 13 Ratio in which the[+] securities will N/A be offered

  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

14
+Class of+securities to which
the offer relates


15
+Record
date
to
determine
entitlements


16
Will
holdings
on
different
registers (or subregisters) be
aggregated
for
calculating
entitlements?


17
Policy for deciding entitlements
in relation to fractions



18
Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.


19
Closing date for receipt of
acceptances or renunciations


20
Names of any underwriters




21
Amount of any underwriting fee
or commission


22
Names of any brokers to the
issue




23
Fee or commission payable to
the broker to the issue


24
Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders


25
If the issue is contingent on
security holders’ approval, the
date of the meeting


26
Date
entitlement
and
acceptance
form
and
offer
documents
will
be
sent
to
persons entitled
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

27 If the entity has issued options, N/A and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders 28 Date rights trading will begin (if N/A applicable) 29 Date rights trading will end (if N/A applicable) 30 How do security holders sell N/A their entitlements in full through a broker? 31 How do security holders sell part N/A of their entitlements through a broker and accept for the balance? 32 How do security holders dispose N/A of their entitlements (except by sale through a broker)? 33 +Issue date N/A

Part 3 -­ Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of[+] securities ( tick one )

(a) +Securities described in Part 1

  • (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

  • 35[If the ] the additional[+][securities are ][+] securities, and the number and percentage of additional[+][equity securities, the names of the 20 largest holders of ] +securities held by those holders

  • 36 +[If the ] securities setting out the number of holders in the categories[+][securities are ][+][equity securities, a distribution schedule of the additional ] 1 -­ 1,000

  • 1,001 -­ 5,000 5,001 -­ 10,000 10,001 -­ 100,000 100,001 and over

  • 37[A copy of any trust deed for the additional ][+][securities ]

Entities that have ticked box 34(b)

  • 38 Number of[+] securities for which +quotation is sought

  • 39 +Class of +securities for which quotation is sought

  • 40 Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state: • the date from which they do

  • • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

  • 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another[+] security, clearly identify that other[+] security)

Number +Class

42 Number and +class of all +securities quoted on ASX ( including the +securities in clause 38)

  • See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-­one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ Date: 1 April 2016 ( ~~Director/~~ Company secretary) Print name: Matt Vaughan

  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

==> picture [415 x 463] intentionally omitted <==

----- Start of picture text -----

Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insert number of fully paid [+] ordinary
securities on issue 12 months before the
+issue date or date of agreement to issue
Add the following:
• Number of fully paid [+] ordinary securities
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid [+] ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid [+] ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid [+] ordinary
securities cancelled during that 12 month
period
“A”
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1
that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period_not counting_those issued:

Under an exception in rule 7.2

Under rule 7.1A

With security holder approval under rule
7.1 or rule 7.4
Note:

This applies to equity securities, unless
specifically excluded – not just ordinary
securities

Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed

It may be useful to set out issues of
securities on different dates as separate
line items
“C”
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
Subtract“C”
Note: number must be same as shown in
Step 3
Total[“A” x 0.15] – “C”
[Note: this is the remaining placement
capacity under rule 7.1]
  • See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013

Part 2

==> picture [415 x 484] intentionally omitted <==

----- Start of picture text -----

Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A”
Note: number must be same as shown in
Step 1 of Part 1
Step 2: Calculate 10% of “A”
“D” 0.10
Note: this value cannot be changed
Multiply “A” by 0.10
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insert number of [+] equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
“E”
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
Subtract“E”
Note: number must be same as shown in
Step 3
Total[“A” x 0.10] – “E”
Note: this is the remaining placement
capacity under rule 7.1A
  • See chapter 19 for defined terms.

Appendix 3B Page 13

04/03/2013